Search Results 1231-1240 of 17186 for monoclonal antibody
... monoclonal antibody, including gemtuzumab ozogamicin, 28 days prior to the first dose of NKX101 Note: Treatment with hydroxyurea is allowed up to 48 hours ...
... monoclonal antibody (mAb) therapy within 45 days prior to study Day 1. Note: Patients are allowed to receive any of the following treatments up to 7 days ...
Engage in Research and Collaborate. Focused research efforts at Mayo Clinic and with collaborators bring genomic discoveries to patient care.
... antibody responses to folate receptor alpha and will have broad evidence of systemic immune activation. Participation eligibility. Participant eligibility ...
Pittock's clinical and laboratory expertise lies in modifying, for clinical application, the antibody assays developed by the Neuroimmunology Research ...
... monoclonal antibodies, other investigational agent) < 28 days prior to the first dose of study drug. Current or prior use of immunosuppressive medication ...
... monoclonal antibody approved by the FDA for the treatment of relapsing MS, or (iii) rituximab. Qualifying DMTs include: dimethyl fumarate, diroximel ...
... Antibody Is Avoided: A Matched Cohort Study. ... Kidney Transplantation in Patients With Monoclonal Gammopathy of Renal Significance (MGRS)-Associated Lesions: A ...
Epidemiology of Monoclonal B-Cell Lymphocytosis Study · Resources · Contact . Mayo Clinic Footer. Request Appointment · Give Now · Contact Us · About Mayo ...
Known severe hypersensitivity reactions to monoclonal antibodies (Grade ≥ 3 NCI-CTC V4.03 or V5.0 for phase II part 2), any history of anaphylaxis, or ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.